MEDINET Co., Ltd.
2370.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.42B
Close$
Share Statistics
| Market cap | $6.42 Billion |
|---|---|
| Enterprise Value | $4.21 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.15 |
| Beta | 0.4 |
| Outstanding Shares | 279,433,675 |
Return
| Return on Equity | -32.28% |
|---|---|
| Return on Assets | -28.95% |
| Return on Invested Capital | -30.65% |
Valuation & Multiples
| P/E Ratio | -5.67 |
|---|---|
| PEG | 20.51 |
| Price to Sales | 7.67 |
| Price to Book Ratio | 1.92 |
| Enterprise Value to Revenue | 4.97 |
| Enterprise Value to EBIT | -3.84 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About MEDINET Co., Ltd.
107 employees
CEO: Kanenao Kubushiro Established in 1995 and headquartered in Tokyo, Japan, MEDINET Co., Ltd. functions as a contract development and manufacturing organization (CDMO) primarily focused on regenerative medicine and cell therapy solutions within Japan. The co...